Contemporary short-term peri-operative outcomes of open primary retroperitoneal lymph node dissection

BJU Int. 2024 Dec;134(6):953-959. doi: 10.1111/bju.16506. Epub 2024 Sep 3.

Abstract

Objectives: To provide current peri-operative outcomes and short-term complication rates for open primary retroperitoneal lymph node dissection (RPLND), with analysis of risk factors for complications.

Patients and methods: Using the Indiana University Testicular Cancer database, we performed a retrospective analysis of all patients who underwent open primary RPLND over the study period (2018-2021). The primary outcomes of interest were the preoperative profile of patients undergoing surgery, complication rates, and identification of risk factors associated with complications. We used chi-squared, Fisher's exact and unpaired t-tests in our analyses.

Results: A total of 165 patients were identified. The median body mass index (BMI) was 28.6 kg/m2. Patients most often had clinical stage IIA (39%) or IIB testicular cancer (36%). The median estimated blood loss was 150 mL, with no transfusions required. Higher BMI was noted in patients that sustained any complication vs those with normal recovery (34.95 vs 28 kg/m2; P = 0.0042). The median length of hospital stay was 3 days. The overall complication rate was low (8.48%), with two major postoperative complications, including one case of chylous ascites (0.6%), and no deaths in the 30-day period. The study was limited by its retrospective design and short-term follow-up.

Conclusions: We found that open primary RPLND has an acceptable morbidity profile, even among a predominantly overweight cohort. Low blood loss, short hospital stay, minimal chylous ascites risk, and rare major postoperative complications should be the benchmark for retroperitoneal lymph node dissection.

Keywords: RPLND; complications; morbidity; outcomes; testicular cancer.

MeSH terms

  • Adult
  • Humans
  • Length of Stay / statistics & numerical data
  • Lymph Node Excision* / adverse effects
  • Lymph Node Excision* / methods
  • Male
  • Middle Aged
  • Neoplasms, Germ Cell and Embryonal / pathology
  • Neoplasms, Germ Cell and Embryonal / surgery
  • Postoperative Complications* / epidemiology
  • Postoperative Complications* / etiology
  • Retroperitoneal Space
  • Retrospective Studies
  • Risk Factors
  • Testicular Neoplasms* / pathology
  • Testicular Neoplasms* / surgery
  • Treatment Outcome
  • Young Adult